Market Movers

Edwards Lifesciences to buy back shares

A minimally invasive heart valve from Edwards.

Associated Press/File 2010

A minimally invasive heart valve from Edwards.


Edwards Lifesciences Corp. said that its board has authorized a program to repurchase up to an additional $750 million worth of the company’s stock, Dow Jones reported. The company has a market capitalization value of $7.6 billion, according­ to FactSet. Separately Tuesday, the company said chief financial officer Thomas M. Abate will retire this year; he turns 60 in August. Edwards is the biggest maker of aortic heart valves implanted with a catheter.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.